FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Shapiro

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Physiology

Concepts & Ideas

Phenomena

Nucleic Acid Hybridization

Co-author Network

Publications

TOP 3
Chen Zhang; Steven K Nordeen; David J Shapiro
Fluorescence anisotropy microplate assay to investigate the interaction of full-length steroid receptor coactivator-1a with steroid receptors.
Neal Andruska; Mathew Cherian; Chengjian Mao; Chen Zhang; David J Shapiro
Evaluation of a luciferase-based reporter assay as a screen for inhibitors of estrogen-ERα-induced proliferation of breast cancer cells.
Milu T Cherian; Elizabeth M Wilson; David J Shapiro
A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Shapiro (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Chen Zhang; Steven K Nordeen; David J Shapiro
Fluorescence anisotropy microplate assay to investigate the interaction of full-length steroid receptor coactivator-1a with steroid receptors.
Methods in molecular biology (Clifton, N.J.) 2013;977():339-51.
2012: Neal Andruska; Mathew Cherian; Chengjian Mao; Chen Zhang; David J Shapiro
Evaluation of a luciferase-based reporter assay as a screen for inhibitors of estrogen-ERα-induced proliferation of breast cancer cells.
Journal of biomolecular screening 2012;17(7):921-32.
2012: Milu T Cherian; Elizabeth M Wilson; David J Shapiro
A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.
The Journal of biological chemistry 2012;287(28):23368-80.
2012: Irene O Aninye; Kenneth C Berg; Andy R Mollo; Steven K Nordeen; Elizabeth M Wilson; David J Shapiro
8-alkylthio-6-thio-substituted theophylline analogues as selective noncompetitive progesterone receptor antagonists.
Steroids 2012;77(6):596-601.
2012: B Huang; K Ito; Y Ito; C W Ong; Z Qu; M Salto-Tellez; David J Shapiro; Y-H N Tsang; G Xiao; Lucy F Chen
RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α.
Oncogene 2012;31(4):527-34.
2011: David J Shapiro; Chengjian Mao; Milu T Cherian
Small molecule inhibitors as probes for estrogen and androgen receptor action.
The Journal of biological chemistry 2011;286(6):4043-8.
2011: Ho-Hyung Woo; Xiaofang Yi; Tiffany Lamb; Ina Menzl; Terri Baker; David J Shapiro; Setsuko K Chambers
Posttranscriptional suppression of proto-oncogene c-fms expression by vigilin in breast cancer.
Molecular and cellular biology 2011;31(1):215-25.
2010: Nicole M Kretzer; Milu T Cherian; Chengjian Mao; Irene O Aninye; Philip D Reynolds; Rachel Schiff; Paul J Hergenrother; Steven K Nordeen; Elizabeth M Wilson; David J Shapiro
A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}.
The Journal of biological chemistry 2010;285(53):41863-73.
2010: Emily Powell; Yidan Wang; David J Shapiro; Wei Xu
Differential requirements of Hsp90 and DNA for the formation of estrogen receptor homodimers and heterodimers.
The Journal of biological chemistry 2010;285(21):16125-34.
2008: Xinguo Jiang; Nicole M Patterson; Yan Ling; Jianwei Xie; William G Helferich; David J Shapiro
Low concentrations of the soy phytoestrogen genistein induce proteinase inhibitor 9 and block killing of breast cancer cells by immune cells.
Endocrinology 2008;149(11):5366-73.
2008: Chengjian Mao; Nicole M Patterson; Milu T Cherian; Irene O Aninye; Chen Zhang; Jamie Bonéy Montoya; Jingwei Cheng; Karson S Putt; Paul J Hergenrother; Elizabeth M Wilson; Carol Curtis; Steven K Nordeen; David J Shapiro
A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells.
The Journal of biological chemistry 2008;283(19):12819-30.
2007: Jingwei Cheng; David V Yu; Jian-Hua Zhou; David J Shapiro
Tamoxifen induction of CCAAT enhancer-binding protein alpha is required for tamoxifen-induced apoptosis.
The Journal of biological chemistry 2007;282(42):30535-43.
2007: Jian-Hua Zhou; David V Yu; Jingwei Cheng; David J Shapiro
Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.
Steroids 2007;72(11-12):765-77.
2007: Jingwei Cheng; Chen Zhang; David J Shapiro
A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen.
Endocrinology 2007;148(10):4634-41.
2007: X Jiang; S J Ellison; Elaine T Alarid; David J Shapiro
Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells.
Oncogene 2007;26(28):4106-14.
2007: Stanley Wang; Chen Zhang; Steven K Nordeen; David J Shapiro
In vitro fluorescence anisotropy analysis of the interaction of full-length SRC1a with estrogen receptors alpha and beta supports an active displacement model for coregulator utilization.
The Journal of biological chemistry 2007;282(5):2765-75.
2007: Thomas D Cunningham; Xinguo Jiang; David J Shapiro
Expression of high levels of human proteinase inhibitor 9 blocks both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity.
Cellular immunology 2007;245(1):32-41.
2006: Chengjian Mao; Kathryn Goolsby Flavin; Stanley Wang; Robin E Dodson; Jeffrey Ross; David J Shapiro
Analysis of RNA-protein interactions by a microplate-based fluorescence anisotropy assay.
Analytical biochemistry 2006;350(2):222-32.
2006: Xinguo Jiang; Brent A Orr; David M Kranz; David J Shapiro
Estrogen induction of the granzyme B inhibitor, proteinase inhibitor 9, protects cells against apoptosis mediated by cytotoxic T lymphocytes and natural killer cells.
Endocrinology 2006;147(3):1419-26.
2004: Stanley Y Wang; Bonnie S Ahn; Rebecca Harris; Steven K Nordeen; David J Shapiro
Fluorescence anisotropy microplate assay for analysis of steroid receptor-DNA interactions.
BioTechniques 2004;37(5):807-8, 810-7.
2004: Adam J Krieg; Sacha A Krieg; Bonnie S Ahn; David J Shapiro
Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes.
The Journal of biological chemistry 2004;279(6):5025-34.
2003: Kathryn M Goolsby; David J Shapiro
RNAi-mediated depletion of the 15 KH domain protein, vigilin, induces death of dividing and non-dividing human cells but does not initially inhibit protein synthesis.
Nucleic acids research 2003;31(19):5644-53.
2003: Robin E Dodson; Kathryn M Goolsby; Maria Acena-Nagel; Chengjian Mao; David J Shapiro
RNA gel shift assays for analysis of hormone control of mRNA stability.
Methods in enzymology 2003;364():350-61.
2002: Maria Obrero; David V Yu; David J Shapiro
Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death.
The Journal of biological chemistry 2002;277(47):45695-703.
2002: Padma Kannan-Thulasiraman; David J Shapiro
Modulators of inflammation use nuclear factor-kappa B and activator protein-1 sites to induce the caspase-1 and granzyme B inhibitor, proteinase inhibitor 9.
The Journal of biological chemistry 2002;277(43):41230-9.
2002: Robin E Dodson; David J Shapiro
Regulation of pathways of mRNA destabilization and stabilization.
Progress in nucleic acid research and molecular biology 2002;72():129-64.
2001: Sacha A Krieg; A J Krieg; David J Shapiro
A unique downstream estrogen responsive unit mediates estrogen induction of proteinase inhibitor-9, a cellular inhibitor of IL-1beta- converting enzyme (caspase 1).
Molecular endocrinology (Baltimore, Md.) 2001;15(11):1971-82.
2000: Chengcheng Zhang; KA Glenn; M A Kuntz; David J Shapiro
High level expression of full-length estrogen receptor in Escherichia coli is facilitated by the uncoupler of oxidative phosphorylation, CCCP.
The Journal of steroid biochemistry and molecular biology 2000;74(4):169-78.
2000: KS Cunningham; Robin E Dodson; M A Nagel; David J Shapiro; Daniel R Schoenberg
Vigilin binding selectively inhibits cleavage of the vitellogenin mRNA 3'-untranslated region by the mRNA endonuclease polysomal ribonuclease 1.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(23):12498-502.
2000: Chengjian Mao; David J Shapiro
A histone deacetylase inhibitor potentiates estrogen receptor activation of a stably integrated vitellogenin promoter in HepG2 cells.
Endocrinology 2000;141(7):2361-9.
2000: G de Haan; S Chusacultanachai; Chengjian Mao; Benita S Katzenellenbogen; David J Shapiro
Estrogen receptor-KRAB chimeras are potent ligand-dependent repressors of estrogen-regulated gene expression.
The Journal of biological chemistry 2000;275(18):13493-501.
2000: H Kanamori; Sacha A Krieg; Chengjian Mao; V A Di Pippo; Stanley Wang; D A Zajchowski; David J Shapiro
Proteinase inhibitor 9, an inhibitor of granzyme B-mediated apoptosis, is a primary estrogen-inducible gene in human liver cells.
The Journal of biological chemistry 2000;275(8):5867-73.
2000: Chengcheng Zhang; David J Shapiro
Activation of the p38 mitogen-activated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis.
The Journal of biological chemistry 2000;275(1):479-86.
1999: S Chusacultanachai; KA Glenn; A O Rodriguez; Erik K Read; Jeffrey F Gardner; Benita S Katzenellenbogen; David J Shapiro
Analysis of estrogen response element binding by genetically selected steroid receptor DNA binding domain mutants exhibiting altered specificity and enhanced affinity.
The Journal of biological chemistry 1999;274(33):23591-8.
1999: H Kanamori; David J Shapiro
Differential display combined with a regulated transient expression system.
BioTechniques 1999;26(6):1018-20.
1999: Chengcheng Zhang; Sacha A Krieg; David J Shapiro
HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells.
Molecular endocrinology (Baltimore, Md.) 1999;13(4):632-43.
1998: H Kanamori; Robin E Dodson; David J Shapiro
In vitro genetic analysis of the RNA binding site of vigilin, a multi-KH-domain protein.
Molecular and cellular biology 1998;18(7):3991-4003.
1997: M A Kuntz; David J Shapiro
Dimerizing the estrogen receptor DNA binding domain enhances binding to estrogen response elements.
The Journal of biological chemistry 1997;272(44):27949-56.
1997: J Kim; G de Haan; Carol Curtis; David J Shapiro
Prebending the estrogen response element destabilizes binding of the estrogen receptor DNA binding domain.
Molecular and cellular biology 1997;17(6):3173-80.
1997: Robin E Dodson; David J Shapiro
Vigilin, a ubiquitous protein with 14 K homology domains, is the estrogen-inducible vitellogenin mRNA 3'-untranslated region-binding protein.
The Journal of biological chemistry 1997;272(19):12249-52.
1997: S Mattick; KA Glenn; G de Haan; David J Shapiro
Analysis of ligand dependence and hormone response element synergy in transcription by estrogen receptor.
The Journal of steroid biochemistry and molecular biology 1997;60(5-6):285-94.
1997: Larry N Petz; Carol Curtis; Jongsook Kim; K B Horwitz; L P Freedman; David J Shapiro
DNA bending is induced by binding of the glucocorticoid receptor DNA binding domain and progesterone receptors to their response element.
The Journal of steroid biochemistry and molecular biology 1997;60(1-2):31-41.
1996: EM McInerney; B A Ince; David J Shapiro; Benita S Katzenellenbogen
A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action.
Molecular endocrinology (Baltimore, Md.) 1996;10(12):1519-26.
1996: J Kim; David J Shapiro
In simple synthetic promoters YY1-induced DNA bending is important in transcription activation and repression.
Nucleic acids research 1996;24(21):4341-8.
1996: J Kim; G de Haan; David J Shapiro
DNA bending between upstream activator sequences increases transcriptional synergy.
Biochemical and biophysical research communications 1996;226(3):638-44.
1995: D J Schodin; Y Zhuang; David J Shapiro; Benita S Katzenellenbogen
Analysis of mechanisms that determine dominant negative estrogen receptor effectiveness.
The Journal of biological chemistry 1995;270(52):31163-71.
1995: B A Ince; D J Schodin; David J Shapiro; Benita S Katzenellenbogen
Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors.
Endocrinology 1995;136(8):3194-9.
1995: Robin E Dodson; M R Acena; David J Shapiro
Tissue distribution, hormone regulation and evidence for a human homologue of the estrogen-inducible Xenopus laevis vitellogenin mRNA binding protein.
The Journal of steroid biochemistry and molecular biology 1995;52(6):505-15.
1995: J H Lee; J Kim; David J Shapiro
Regulation of Xenopus laevis estrogen receptor gene expression is mediated by an estrogen response element in the protein coding region.
DNA and cell biology 1995;14(5):419-30.
1995: Y Zhuang; Benita S Katzenellenbogen; David J Shapiro
Estrogen receptor mutants which do not bind 17 beta-estradiol dimerize and bind to the estrogen response element in vivo.
Molecular endocrinology (Baltimore, Md.) 1995;9(4):457-66.
1995: H Xing; S Mattick; D Lew; David J Shapiro
An N-terminal deletion mutant of estrogen receptor exhibits increased synergism with upstream activators and enhanced binding to the estrogen response element.
Biochemistry 1995;34(12):3956-63.
1995: J Kim; S Klooster; David J Shapiro
Intrinsically bent DNA in a eukaryotic transcription factor recognition sequence potentiates transcription activation.
The Journal of biological chemistry 1995;270(3):1282-8.
1994: H Xing; Steven C Haase; David J Shapiro
Antiestrogens activate an estrogen receptor mutant exhibiting enhanced binding to the estrogen response element.
Biochemical and biophysical research communications 1994;202(2):888-95.
1994: Francois Claret; S Chapel; J Garcés; Monika Tsai-Pflugfelder; C Bertholet; David J Shapiro; Riccardo Wittek; Walter Wahli
Two functional forms of the Xenopus laevis estrogen receptor translated from a single mRNA species.
The Journal of biological chemistry 1994;269(19):14047-55.
1994: Robin E Dodson; David J Shapiro
An estrogen-inducible protein binds specifically to a sequence in the 3' untranslated region of estrogen-stabilized vitellogenin mRNA.
Molecular and cellular biology 1994;14(5):3130-8.
1993: H Xing; David J Shapiro
An estrogen receptor mutant exhibiting hormone-independent transactivation and enhanced affinity for the estrogen response element.
The Journal of biological chemistry 1993;268(31):23227-33.
1993: B A Ince; Y Zhuang; C K Wrenn; David J Shapiro; Benita S Katzenellenbogen
Powerful dominant negative mutants of the human estrogen receptor.
The Journal of biological chemistry 1993;268(19):14026-32.
1993: Carol Curtis; Geoffrey L Greene; David J Shapiro
Human estrogen receptor bound to an estrogen response element bends DNA.
Molecular endocrinology (Baltimore, Md.) 1993;7(3):331-40.
1993: Carol Curtis; David J Shapiro
DNA bending by nuclear receptors.
Receptor 1993;3(4):247-55.
1992: Carol Curtis; David J Shapiro
Binding of the estrogen receptor DNA-binding domain to the estrogen response element induces DNA bending.
Molecular and cellular biology 1992;12(5):2037-42.
1992: T C Chang; Carol Curtis; D Lew; David J Shapiro
The role of estrogen response elements in expression of the Xenopus laevis vitellogenin B1 gene.
Molecular endocrinology (Baltimore, Md.) 1992;6(3):346-54.
1991: Carol Curtis; D Lew; L Erijman; David J Shapiro
Purified estrogen receptor DNA binding domain expressed in Escherichia coli activates transcription of an estrogen-responsive promoter in cultured cells.
The Journal of biological chemistry 1991;266(35):24070-6.
1990: D A Nielsen; David J Shapiro
Insights into hormonal control of messenger RNA stability.
Molecular endocrinology (Baltimore, Md.) 1990;4(7):953-7.
1990: T C Chang; David J Shapiro
An NF1-related vitellogenin activator element mediates transcription from the estrogen-regulated Xenopus laevis vitellogenin promoter.
The Journal of biological chemistry 1990;265(14):8176-82.
1990: H J Chen; David J Shapiro
Nucleotide sequence and estrogen induction of Xenopus laevis 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
The Journal of biological chemistry 1990;265(8):4622-9.
1990: D A Nielsen; David J Shapiro
Estradiol and estrogen receptor-dependent stabilization of a minivitellogenin mRNA lacking 5,100 nucleotides of coding sequence.
Molecular and cellular biology 1990;10(1):371-6.
1989: J E Blume; David J Shapiro
Ribosome loading, but not protein synthesis, is required for estrogen stabilization of Xenopus laevis vitellogenin mRNA.
Nucleic acids research 1989;17(22):9003-14.
1989: D A Nielsen; T C Chang; David J Shapiro
A highly sensitive, mixed-phase assay for chloramphenicol acetyltransferase activity in transfected cells.
Analytical biochemistry 1989;179(1):19-23.
1989: David J Shapiro; M C Barton; D M McKearin; T C Chang; D Lew; J Blume; D A Nielsen; L Gould
Estrogen regulation of gene transcription and mRNA stability.
Recent progress in hormone research 1989;45():29-58; discussion 58-64.
1988: M C Barton; David J Shapiro
Transient administration of estradiol-17 beta establishes an autoregulatory loop permanently inducing estrogen receptor mRNA.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(19):7119-23.
1988: D M McKearin; David J Shapiro
Persistent estrogen induction of hepatic Xenopus laevis serum retinol binding protein mRNA.
The Journal of biological chemistry 1988;263(7):3261-5.
1988: David J Shapiro; Phillip A Sharp; W W Wahli; M J Keller
A high-efficiency HeLa cell nuclear transcription extract.
DNA (Mary Ann Liebert, Inc.) 1988;7(1):47-55.
1987: David J Shapiro; J E Blume; D A Nielsen
Regulation of messenger RNA stability in eukaryotic cells.
BioEssays : news and reviews in molecular, cellular and developmental biology 1987;6(5):221-6.
1987: I J Weiler; D Lew; David J Shapiro
The Xenopus laevis estrogen receptor: sequence homology with human and avian receptors and identification of multiple estrogen receptor messenger ribonucleic acids.
Molecular endocrinology (Baltimore, Md.) 1987;1(5):355-62.
1987: D M McKearin; M C Barton; M J Keller; David J Shapiro
Estrogen induces transcription of the Xenopus laevis serum retinol-binding protein gene.
The Journal of biological chemistry 1987;262(11):4939-42.
1986: D A Nielsen; David J Shapiro
Preparation of capped RNA transcripts using T7 RNA polymerase.
Nucleic acids research 1986;14(14):5936.
1986: C L Jackson; David J Shapiro
Dexamethasone and estrogen regulate Xenopus laevis albumin mRNA levels.
Biochemical and biophysical research communications 1986;136(1):8-15.
1985: G G Martin; David J Shapiro
Regulation of rat liver cell 3-hydroxy-3-methylglutaryl coenzyme A reductase by methoxypolyoxyethylated cholesterol.
Biochimica et biophysica acta 1985;837(2):163-72.
1985: G A Keller; M C Barton; David J Shapiro; S J Singer
3-Hydroxy-3-methylglutaryl-coenzyme A reductase is present in peroxisomes in normal rat liver cells.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(3):770-4.
1985: M A Hayward; M C Barton; David J Shapiro
Coordinate estrogen induction of vitellogenin and a small serum protein mRNA in Xenopus laevis liver.
Molecular and cellular endocrinology 1985;39(2):91-8.
1983: M L Brock; David J Shapiro
Estrogen stabilizes vitellogenin mRNA against cytoplasmic degradation.
Cell 1983;34(1):207-14.
1983: K Folger; J N Anderson; M A Hayward; David J Shapiro
Nuclease sensitivity and DNA methylation in estrogen regulation of Xenopus laevis vitellogenin gene expression.
The Journal of biological chemistry 1983;258(14):8908-14.
1983: M L Brock; David J Shapiro
Estrogen regulates the absolute rate of transcription of the Xenopus laevis vitellogenin genes.
The Journal of biological chemistry 1983;258(9):5449-55.
1982: M A Hayward; M L Brock; David J Shapiro
Activation of vitellogenin gene transcription is a direct response to estrogen in Xenopus laevis liver.
Nucleic acids research 1982;10(24):8273-84.
1982: B W Philipp; E A Morgan; David J Shapiro
Quantitation of estrogen effect on Xenopus laevis albumin mRNA levels by hybridization to cloned albumin cDNA.
The Journal of biological chemistry 1982;257(14):8496-501.
1982: M A Hayward; M L Brock; David J Shapiro
The role of estrogen receptor in Xenopus laevis vitellogenin gene expression.
The American journal of physiology 1982;243(1):C1-6.
1982: R E Clark; G G Martin; M C Barton; David J Shapiro
Production and characterization of monoclonal antibodies to rat liver microsomal 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(12):3734-8.
1982: David J Shapiro
Steroid hormone regulation of vitellogenin gene expression.
CRC critical reviews in biochemistry 1982;12(3):187-203.
1981: M A Hayward; David J Shapiro
A middle-affinity estrogen-specific binding protein in livers of vitellogenic and nonvitellogenic Xenopus laevis.
Developmental biology 1981;88(2):333-40.
1981: B W Philipp; David J Shapiro
Estrogen regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and acetyl-CoA carboxylase in xenopus laevis.
The Journal of biological chemistry 1981;256(6):2922-7.
1981: David J Shapiro
Quantitative ethanol precipitation of nanogram quantities of DNA and RNA.
Analytical biochemistry 1981;110(1):229-31.
1980: M A Hayward; T A Mitchell; David J Shapiro
Induction of estrogen receptor and reversal of the nuclear/cytoplasmic receptor ratio during vitellogenin synthesis and withdrawal in Xenopus laevis.
The Journal of biological chemistry 1980;255(23):11308-12.
1979: B W Philipp; David J Shapiro
Improved methods for the assay and activation of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Journal of lipid research 1979;20(5):588-93.
1979: David J Shapiro; M J Blumenkrantz; S R Levin; J W Coburn
Absorption and action of insulin added to peritoneal dialysate in dogs.
Nephron 1979;23(4):174-80.
1978: H J Baker; David J Shapiro
Rapid accumulation of vitellogenin messenger RNA during secondary estrogen stimulation of Xenopus laevis.
The Journal of biological chemistry 1978;253(13):4521-4.
1977: H J Baker; David J Shapiro
Kinetics of estrogen induction of Xenopus laevis vitellogenin messenger RNA as measured by hybridization to complementary DNA.
The Journal of biological chemistry 1977;252(23):8428-34.
1977: David J Shapiro; H J Baker
Purification and characterization of Xenopus laevis vitellogenin messenger RNA.
The Journal of biological chemistry 1977;252(15):5244-50.
1976: David J Shapiro; H J Baker; D T Stitt
In vitro translation and estradiol-17beta induction of Xenopus laevis vitellogenin messenger RNA.
The Journal of biological chemistry 1976;251(10):3105-111.
1975: David J Shapiro; M J Blumenkrantz; J H Shinaberger; J W Coburn
Useful function of "non-functioning" renal homograft.
British medical journal 1975;3(5976):140.
1975: M J Blumenkrantz; David J Shapiro; M E Swendseid; J D Kopple
Histidine supplementation for treatment of anaemia of uraemia.
British medical journal 1975;2(5970):530-3.
1975: David J Shapiro; R T Schimke
Immunochemical isolation and characterization of ovalbumin messenger ribonucleic acid.
The Journal of biological chemistry 1975;250(5):1759-64.
1975: R T Schimke; David J Shapiro; G S McKnight
Ovalbumin mRNA and ovalbumin DNA and the molecular biology of steroid hormone action.
Advances in experimental medicine and biology 1975;62():79-101.
1975: R T Schimke; G S McKnight; David J Shapiro; D Sullivan; R Palacios
Hormonal regulation of ovalbumin synthesis in the chick oviduct.
Recent progress in hormone research 1975;31():175-211.
1974: David J Shapiro; J L Nordstrom; J J Mitschelen; V W Rodwell; R T Schimke
Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts.
Biochimica et biophysica acta 1974;370(2):369-77.
1974: M J Blumenkrantz; David J Shapiro; N Mimura; D G Greopoulus; R M Griedler; S Levin; H Tenckhoff; J W Coburn
Maintenance peritoneal dialysis as an alternative in the patient with diabetes mellitus and end-stage uremia.
Kidney international. Supplement 1974;(1):108-14.
1974: David J Shapiro; J M Taylor; G S McKnight; R Palacios; C Gonzalez; M L Kiely; R T Schimke
Isolation of hen oviduct ovalbumin and rat live albumin polysomes by indirect immunoprecipitation.
The Journal of biological chemistry 1974;249(12):3665-71.
1974: M J Blumenkrantz; David J Shapiro; M E Swendseid; J D Kopple
The effect of histidine supplementation on the anemia of uremia.
Proceedings of the Clinical Dialysis and Transplant Forum 1974;(4):152-5.
1973: M J Blumenkrantz; David J Shapiro; J H Miller; M Barshay; J D Kopple; J H Shinaberger; R M Friedler; J W Coburn
Chronic peritoneal dialysis for the management of chronic renal failure.
Proceedings of the Clinical Dialysis and Transplant Forum 1973;3():117-21.
1972: David J Shapiro; V W Rodwell
Fine structure of the cyclic rhythm of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Differential effects of cholesterol feeding and fasting.
Biochemistry 1972;11(6):1042-5.
1971: David J Shapiro; V W Rodwell
Regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol synthesis.
The Journal of biological chemistry 1971;246(10):3210-6.
1969: David J Shapiro; V W Rodwell
Diurnal variation and cholesterol regulation of hepatic HMG-CoA reductase activity.
Biochemical and biophysical research communications 1969;37(5):867-72.
1969: David J Shapiro; R L Imblum; V W Rodwell
Thin-layer chromatographic assay for HMG-CoA reductase and mevalonic acid.
Analytical biochemistry 1969;31(1):383-90.